Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)

Ginkgo Bioworks Holdings' (DNA) quarterly Change in Working Capital came in at $4.7 million in Q2 2023, up 76.52% YoY from $2.7 million in Q2 2022, and down 44.5% on a QoQ basis from $8.5 million in Q1 2023.

Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023) Analysis & Trends

Ginkgo Bioworks Holdings (DNA) has 2 years of Change in Working Capital data on file, last reported at $4.7 million in Q2 2023.

  • Quarterly Change in Working Capital rose 76.52% year-over-year to $4.7 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18.6 million (changed N/A YoY) and the FY2022 annual result came in at $10.8 million, changed N/A from the prior year.
  • Change in Working Capital retreated to $4.7 million in Q2 2023, from $8.5 million in the prior quarter.
  • In the past five years, Change in Working Capital ranged from a high of $8.5 million in Q1 2023 to a low of $2.7 million in Q1 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Ginkgo Bioworks Holdings 432.60 Mn 348.06 Mn 18.44 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 4.73 Mn
Jun 30, 2023 4.73 Mn
Mar 31, 2023 8.52 Mn
Mar 31, 2023 8.52 Mn
Jun 30, 2022 2.68 Mn
Jun 30, 2022 2.68 Mn
Mar 31, 2022 2.65 Mn
Mar 31, 2022 2.65 Mn